Reduce Complications Associated with Implantable Devices.
CanGaroo reduces scarring and promotes healthy controlled healing.1,2,3
Make patient care more predictable and manageable with the CanGaroo Envelope. CanGaroo regulates the biologic healing response post implant, reduces inflammation, and mitigates excessive scar tissue formation and the associated complications.1,2,3
CanGaroo is an extracellular matrix that creates a hospitable environment for host cells to migrate and initiate tissue remodeling, stabilizing the device in healthy vascularized tissue.2
Representative product shown.
More than 1,200 institutions trust Aziyo products for their patients. Physicians, like Dr. Koide use CanGaroo to reduce complications associated with pocket scarring that could lead to difficult change-outs and increase risk for infection.4,5
CanGaroo. For Life.
CanGaroo restores the natural anatomy post implant.1,2 It encourages healthy tissue growth by creating a hospitable environment for host cells to migrate and propagate into the ECM bio scaffold.1,2,3 The new healthy tissue secures and can protect the implanted CIED for the life of the device. Using a CanGaroo at implant is simple and helps make patient care more predictable.
Avoid Scar Tissue.
Dr. Niuton S. Koide MD, FACC
Cardiac Electrophysiologist in Las Vegas, Nevada
“We recently had a case where we implanted a pacemaker and used the CanGaroo Envelope. Three to four months later we had to reopen the pocket to upgrade the device. It was really exciting because everyone in the room wanted to see how the pocket had healed. We saw healthy viable tissue around the pacemaker and no fibrotic capsule or CanGaroo Envelope. It was completely replaced by healthy tissue. We all learned that yes, the product does work.”
Asad Mohammad, DO
Mount Sinai Hospital, New York
The First. The Only.
The CanGaroo is the first and only natural biologic envelope designed to help reduce complications with CIED implants.
An extracellular matrix derived from porcine small intestine submucosa, the CanGaroo Envelope regulates the biologic healing response to decrease inflammation and stimulate formation of healthy tissue.2,3 It’s soft and pliable and easily conforms to the shape of the implantable device.
ECM. How It Works.
The CanGaroo easily conforms to the shape of the CIED. Once implanted, CanGaroo Envelope creates a hospitable environment for the surrounding cells to migrate into the bio scaffold and start matrix turnover.1,2
The SIS ECM regulates the biologic healing response triggered from the procedure to reduce inflammation and modulate healing to prevent excessive scar tissue formation.2,3 During remodeling, antimicrobial peptides are released and angiogenesis occurs.2,3
Post Tissue Remodeling
As remodeling concludes the CIED is secured naturally with the new tissue.1,2 The result is systemically connected vascularized tissue that surrounds the device instead of a hypovascular fibrotic capsule.1,2
Dr. Cantanzaro Webinar
In this webinar Dr. Catanzaro reviews extracellular matrix function, S-ICD literature, and implantation recommendations for S-ICDs.
How to Use CanGaroo
In this video you will learn how to prepare the CanGaroo for implantation.
S-ICD Case Report
Dr. Nayak, from the University of Chicago shares his experience implanting an S-ICD with a CanGaroo Envelope and discusses key learnings.
Sizing and Ordering Information
- Product Numbers are for U.S. only.
- For International Sales Contact Customer Service.
Available in 5 Sizes, Multiple Packaging Options, Extended Shelf Life
- Available in 2 packaging configurations, 2.5 year shelf life (30 months)
*Sub-Q size only available in the U.S.
|wdt_ID||Size||Dimensions||Recommended Device Size|
|1||Small||5.4cm x 5.0cm||Pediatric Pacemaker|
|2||Medium||6.9cm x 6.5cm||Pacemaker|
|3||Large||6.9cm x 8.0cm||ICD|
|4||X-Large||6.9cm x 9.5cm||CRT-D and ICD|
|5||Sub-Q*||10.8cm x 8.9cm||S-ICD|
|1||CMCV–009–SML||CanGaroo® Envelope, S, Single Pack|
|2||CMCV–009-MED||CanGaroo® Envelope, M, Single Pack|
|3||CMCV–009-LRG||CanGaroo® Envelope, L, Single Pack|
|4||CMCV–009-XLG||CanGaroo® Envelope, XL, Single Pack|
|5||CMCV–009-XXL||CanGaroo® Envelope, XXL, Single Pack|
|6||CMCV–010–SML||CanGaroo® Envelope, S, Five Pack|
|7||CMCV–010-MED||CanGaroo® Envelope, M, Five Pack|
|8||CMCV–010-LRG||CanGaroo® Envelope, L, Five Pack|
|9||CMCV–010-XLG||CanGaroo® Envelope, XL, Five Pack|
|10||CMCV–010-XXL||CanGaroo® Envelope, XXL, Five Pack|
IFU for U.S. only.
Live Webinar February 17th
Clinical Benefits Leading to Long-Term CIED Pocket Health
Dr. Benjamin D'Souza from Penn Presbyterian Medical Center discusses his clinical experience with the CanGaroo Envelope and clinical benefits leading to long-term CIED pocket health.
1. Aziyo Biologics Data on File
2. Based on preclinical data on file
3. Dziki JL, et al. J Biomed Mater Res A. 2017;105(1):138–147. doi:10.1002/jbm.a.35894.
4. Maytin M, et al. Journal of Innovations in Cardiac Rhythm Management. 2015;6(11):2173-2177. doi:10.19102/icrm.2015.061101.
5. Wilkoff BL. Tex Heart Inst J. 2011;38(4):353–354.